Hapbee, Biotech Stock Review

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
BioSig, Biotech Stock Review

BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems

Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence Westport,...
Dr. Marc Hellerstein

Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To The Rescue.

Pandemic-weary residents everywhere are holding their breath for the first coronavirus vaccines to be approved by federal regulators. The shots, currently being...

Hepion Pharma Doses First Patient in the ‘AMBITION’ Clinical Trial.

Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH.
Cyclophilin, Biotech Stock Review

Adding Hepion Pharma (HEPA) $1.73 to Watch List.

Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here? Oh my…and Oh boy....
Internet Stock Review

Newsletter: Institutional Analyst. And Yes, We Have Another Double.

1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....

Dalrada (DFCO) Appoints Gregory L. Remsen To Vice President of Strategic Relationships.

Dalrada Financial Corporation Appoints Gregory L. Remsen To Vice President of Strategic Relationships DALRADA NEWS ARCHIVE

Committed to Win. C-1 and Dyadic’s (DYAI) Drive to Make Vaccines Affordable Worldwide.

Dyadic International, Inc. (NASDAQ: DYAI) – We are a global biotechnology company focused on further improving and leveraging the patented and proprietary...
Dalrada

Dalrada (DFCO) Finally Pops. Up 59% Today.

Up 59% today on news and with 4 million shares trading and counting! LIVE QUOTE
Hapbee

Adding Hapbee (HAPB) to the Watch List.

Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...